Skip to content

MDMA: all studies

Page 187 of 346: studies 1,861 to 1,870 of 3,454, newest first. Back to the MDMA overview

Research

Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine.

Neuroscience September 1996 T Obradovic, K M Imel, S R White

Methylenedioxymethamphetamine (MDMA) is a mood-altering, legally restricted drug that has been reported to inhibit glutamate-evoked firing of cells in the nucleus accumbens. This study used extracellular recording combined with microiontophoresis to examine whether the inhibitory effect of MDMA on neuronal firing in the nucleus accumbens is mediated by serotonin and/or dopamine. Serotonin and...

MDMA induced hyperthermia: report of a fatality and review of current therapy.

Intensive care medicine September 1996 K J Dar, M E McBrien

Ingestion of 3,4-methylene dioxymethamphetamine (MDMA), commonly known as "Ecstasy", can produce toxicity that is characterised by hyperthermia, coagulopathy, rhabdomyolysis and renal failure. We report a fatality associated with MDMA ingestion and briefly review the current literature on MDMA-induced hyperthermia.

Ecstasy induced pneumomediastinum.

Thorax September 1, 1996 K. Rezvani, Arvinder S Kurbaan, D. Brenton 19 citations

Two cases are reported of pneumomediastinum induced by the use of Ecstasy, a semi-synthetic hallucinogenic compound related to amphetamine and mescaline which has become established as a recreational drug in the UK since the late 1980s. Both cases recovered without incident, but it is important that the possible complications of this drug be publicised so that at risk subjects can be diagnosed...

Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness.

BMJ August 1, 1996 J M Stell, J M Ryan

EDITOR,—We were interested in A Richard Green and Guy M Goodwin's editorial on ecstasy and neurodegeneration.1 We wish to draw attention to another recreational drug, which is taken in similar circumstances to ecstasy, whose use can lead to acute neurological effects. (gamma)-Hydroxybutyrate—also known as GHB, sodium oxybate, GBH, and liquid ecstasy—has been available in Britain since 1994,...

DOI: 10.1136/bmj.313.7054.424a (opens in new tab) Full text (opens in new tab) Humans Seizures Unconsciousness Substance-related disorders +4

Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.

Neuropsychopharmacology August 1996 J H Kehne, H J Ketteler, T C McCloskey et al.

(+/-)3,4-Methylenedioxymethamphetamine (MDMA) releases dopamine and serotonin in vivo and stimulates locomotor activity. Previous work demonstrated that MDMA-stimulated dopamine release could be reduced by the selective 5-HT2A receptor antagonist [R-(+)-a- (2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinem ethanol] (MDL 100,907). In the present study MDL 100,907 significantly...

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Drug safety August 1996 U D McCann, S O Slate, George A. Ricaurte

3,4-Methylenedioxymethamphetamine (MDMA; 'ecstasy') is an increasingly popular recreational drug in the US, Western Europe and Australia. In animals, including nonhuman primates, MDMA is known to damage brain serotonin (5-hydroxytryptamine; 5-HT) neurons. It is not known whether MDMA damages serotonin neurons in the human brain but there is some indication that it may. Although the large...

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

Progress in Neurobiology August 1996 S R White, T Obradovic, K M Imel et al.

Methylenedioxymethamphetamine (MDMA, Ecstasy) is a popular recreationally used drug among young people in Europe and North America. The recent surge in use of MDMA and increasing concerns about possible toxic effects of the drug have inspired a great deal of research into the mechanisms by which the drug may affect the central nervous system. This paper reviews studies on the neurochemical,...

Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

Journal of Pharmacology and Experimental Therapeutics July 1, 1996 Jessica E. Malberg, K E Sabol, Lewis S. Seiden

The substituted amphetamine 3,4-methylenedioxymethamphetamine (MDMA) has been shown to be neurotoxic to serotonin (5HT) terminals in the rat, and rat body temperature (TEMP) has been shown to affect this neurotoxicity. This study looked at the effect on CORE TEMP of three drugs that protect against MDMA neurotoxicity in the rat. Male Holtzmann rats were injected with a control saline (SAL)...

DOI: 10.1016/s0022-3565(25)20131-8 (opens in new tab) Animals Rats N-methyl-3,4-methylenedioxyamphetamine Fluoxetine +5

Cerebral oedema after ingestion of MDMA (“ecstasy”) and unrestricted intake of water

BMJ May 25, 1996 S M Matthai, J A Sills, D C Davidson et al. 68 citations

EDITOR,—3, 4-Methylenedioxymethamphetamine (MDMA or “ecstasy”) is a synthetic derivative of amphetamine and a popular recreational drug among young people. It is known to cause severe hyperpyrexia, dehydration, and rhabdomyolysis.1 Unrestricted ingestion of water is commonly believed to be important in combating some of the side effects of ingestion of the drug. We report on two patients who...

Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons

Synapse May 1, 1996 Andrew N. Gifford, Yoshio Minabe, Alon Toor et al. 7 citations

Extracellular single cell recording was used to examine the effect of intravenous administration of (-), (+), and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) on A10 dopamine (DA) neurons in chloral hydrate anesthetized male rats. Both (+/-)-MDMA and (+)-MDMA inhibited the firing rate of most (79%) A10 DA cells. By contrast, (-)-MDMA induced either no effect or a slight increase in the firing...